Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Does not alter device or atherosclerosis management; leaves open targeted platelet studies for thromboembolic prevention.
In view of the rare presence of studies concerning platelet function as risk factor in atherosclerotic patients, processes underlying thromboembolic events are reviewed in this paper. The morphology and the structural organization-membrane receptors, the open canalicular and dense tubular systems, the cytoskeleton, mitochondria, granules, lysosomes, and peroxisomes-of platelets are described. Platelet function under physiological conditions in atherosclerosis and after implantation of cardiovascular devices is summarized.
No takes yet. Share an insight, caveat, or question.
Reinthaler et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: